US 9878033
Immunogenic peptides for treatment of herpes simplex virus infection and conditions
granted A61KA61K2039/55561A61K2039/57
Quick answer
US patent 9878033 (Immunogenic peptides for treatment of herpes simplex virus infection and conditions) held by The Regents of the University of California expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/55561, A61K2039/57, A61K39/12, A61K39/245